ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $357,000 | -46.8% | 23,505 | -41.2% | 0.00% | -50.0% |
| Q2 2018 | $671,000 | -0.7% | 39,960 | -3.5% | 0.00% | -20.0% |
| Q1 2018 | $676,000 | -15.8% | 41,410 | -34.0% | 0.01% | 0.0% |
| Q4 2017 | $803,000 | +331.7% | 62,704 | +314.1% | 0.01% | +400.0% |
| Q3 2017 | $186,000 | +73.8% | 15,141 | +18.9% | 0.00% | 0.0% |
| Q2 2017 | $107,000 | +1.9% | 12,737 | +8.3% | 0.00% | 0.0% |
| Q1 2017 | $105,000 | -1.9% | 11,765 | -3.3% | 0.00% | 0.0% |
| Q4 2016 | $107,000 | +21.6% | 12,164 | -6.9% | 0.00% | 0.0% |
| Q3 2016 | $88,000 | +49.2% | 13,071 | -21.3% | 0.00% | – |
| Q2 2016 | $59,000 | +13.5% | 16,619 | -5.2% | 0.00% | – |
| Q1 2016 | $52,000 | -7.1% | 17,529 | +32.6% | 0.00% | – |
| Q4 2015 | $56,000 | -29.1% | 13,222 | -23.6% | 0.00% | -100.0% |
| Q3 2015 | $79,000 | +102.6% | 17,295 | +216.5% | 0.00% | – |
| Q2 2015 | $39,000 | +44.4% | 5,464 | +51.8% | 0.00% | – |
| Q1 2015 | $27,000 | +58.8% | 3,599 | +0.1% | 0.00% | – |
| Q4 2014 | $17,000 | +13.3% | 3,594 | -12.5% | 0.00% | – |
| Q3 2014 | $15,000 | -16.7% | 4,108 | +2.0% | 0.00% | – |
| Q2 2014 | $18,000 | -10.0% | 4,027 | -6.0% | 0.00% | – |
| Q1 2014 | $20,000 | 0.0% | 4,286 | +8.9% | 0.00% | – |
| Q4 2013 | $20,000 | -78.3% | 3,935 | -73.3% | 0.00% | -100.0% |
| Q3 2013 | $92,000 | +170.6% | 14,722 | +95.1% | 0.00% | – |
| Q2 2013 | $34,000 | – | 7,547 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |